Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Emergency Medicine
Volume 2014, Article ID 167098, 3 pages
http://dx.doi.org/10.1155/2014/167098
Case Report

A Gut Gone to Pot: A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid

The Reading Health System, 6th Avenue and Spruce Street, West Reading, PA 19611, USA

Received 23 February 2014; Accepted 21 April 2014; Published 29 April 2014

Academic Editor: Han P. Wu

Copyright © 2014 Anene Ukaigwe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Y. Hopkins and B. L. Gilchrist, “A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids,” The Journal of Emergency Medicine, vol. 45, no. 4, pp. 544–546, 2013. View at Google Scholar
  2. T. Leggett and United Nations Office on Drugs and Crime, “A review of the world cannabis situation,” Bulletin on Narcotics, vol. 58, no. 1-2, pp. 1–155, 2006. View at Google Scholar
  3. W. M. Compton, B. F. Grant, J. D. Colliver, M. D. Glantz, and F. S. Stinson, “Prevalence of Marijuana Use Disorders in the United States: 1991-1992 and 2001-2002,” Journal of the American Medical Association, vol. 291, no. 17, pp. 2114–2121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. D. A. Patterson, E. Smith, M. Monahan et al., “Cannabinoid hyperemesis and compulsive bathing: a case series and paradoxical pathophysiological explanation,” Journal of the American Board of Family Medicine, vol. 23, no. 6, pp. 790–793, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Soriano-Co, M. Batke, and M. S. Cappell, “The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the united states,” Digestive Diseases and Sciences, vol. 55, no. 11, pp. 3113–3119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Galli, R. A. Sawaya, and F. K. Friedenberg, “Cannabinoid hyperemesis syndrome,” Current Drug Abuse Reviews, vol. 4, no. 4, pp. 241–249, 2011. View at Google Scholar · View at Scopus
  7. H. A. Enuh, J. Chin, and J. Nfonoyim, “Cannabinoid hyperemesis syndrome with extreme hydrophilia,” International Journal of General Medicine, vol. 6, pp. 685–687, 2013. View at Publisher · View at Google Scholar
  8. D. A. Simonetto, A. S. Oxentenko, M. L. Herman, and J. H. Szostek, “Cannabinoid hyperemesis: a case series of 98 patients,” Mayo Clinic Proceedings, vol. 87, no. 2, pp. 114–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. J. Budney, R. G. Vandrey, and C. Stanger, “Pharmacological and psychosocial interventions for cannabis use disorders,” Revista Brasileira de Psiquiatria, vol. 32, supplement 1, pp. S46–S55, 2010. View at Google Scholar · View at Scopus
  10. W. C. Rodrigues, P. Catbagan, S. Rana et al., “Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS,” Journal of Analytical Toxicology, vol. 37, no. 8, pp. 526–533, 2013. View at Google Scholar